Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022

 

Upgrades

  • Keefe, Bruyette & Woods upgraded the previous rating for Regions Financial Corp RF from Underperform to Market Perform. For the first quarter, Regions Financial had an EPS of $0.55, compared to year-ago quarter EPS of $0.63. The current stock performance of Regions Financial shows a 52-week-high of $25.57 and a 52-week-low of $18.02. Moreover, at the end of the last trading period, the closing price was at $21.89.
  • Goldman Sachs upgraded the previous rating for Voya Financial Inc VOYA from Neutral to Buy. Voya Financial earned $1.47 in the first quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of $74.97 and a 52-week-low of $58.97. At the end of the last trading period, Voya Financial closed at $67.82.
  • According to B. Riley Securities, the prior rating for Ciena Corp CIEN was changed from Neutral to Buy. For the second quarter, Ciena had an EPS of $0.50, compared to year-ago quarter EPS of $0.62. The stock has a 52-week-high of $78.28 and a 52-week-low of $46.60. At the end of the last trading period, Ciena closed at $50.68.
  • For Cornerstone Building Brands Inc CNR, CIBC upgraded the previous rating of Neutral to Outperformer. Cornerstone Building earned $0.66 in the first quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $24.61 and a 52-week-low of $13.51. At the end of the last trading period, Cornerstone Building closed at $24.53.
  • For Ecolab Inc ECL, Credit Suisse upgraded the previous rating of Neutral to Outperform. Ecolab earned $0.82 in the first quarter, compared to $0.81 in the year-ago quarter. The current stock performance of Ecolab shows a 52-week-high of $238.93 and a 52-week-low of $154.31. Moreover, at the end of the last trading period, the closing price was at $173.13.
  • Goldman Sachs upgraded the previous rating for Portland General Electric Co POR from Neutral to Buy. In the first quarter, Portland Gen Electric showed an EPS of $0.67, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $57.03 and a 52-week-low of $45.40. Portland Gen Electric closed at $49.35 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Martin Marietta Materials Inc MLM was changed from Neutral to Overweight. Martin Marietta Materials earned $0.39 in the first quarter, compared to $1.04 in the year-ago quarter. The stock has a 52-week-high of $446.46 and a 52-week-low of $316.73. At the end of the last trading period, Martin Marietta Materials closed at $347.33.

See all analyst ratings upgrades.

 

Downgrades

  • For Huntington Bancshares Inc HBAN, Keefe, Bruyette & Woods downgraded the previous rating of Market Perform to Underperform. In the first quarter, Huntington Bancshares showed an EPS of $0.32, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $17.79 and a 52-week-low of $12.55. At the end of the last trading period, Huntington Bancshares closed at $13.80.
  • For Marsh & McLennan Companies Inc MMC, Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. In the first quarter, Marsh & McLennan showed an EPS of $2.30, compared to $1.99 from the year-ago quarter. The stock has a 52-week-high of $183.14 and a 52-week-low of $133.86. At the end of the last trading period, Marsh & McLennan closed at $160.09.
  • According to Morgan Stanley, the prior rating for Aon PLC AON was changed from Equal-Weight to Underweight. For the first quarter, Aon had an EPS of $4.83, compared to year-ago quarter EPS of $4.28. The current stock performance of Aon shows a 52-week-high of $341.98 and a 52-week-low of $223.19. Moreover, at the end of the last trading period, the closing price was at $278.63.
  • According to B of A Securities, the prior rating for JOANN Inc JOAN was changed from Buy to Neutral. JOANN earned $0.22 in the first quarter, compared to $0.46 in the year-ago quarter. The current stock performance of JOANN shows a 52-week-high of $17.50 and a 52-week-low of $7.00. Moreover, at the end of the last trading period, the closing price was at $7.90.
  • For Westlake Corp WLK, JP Morgan downgraded the previous rating of Overweight to Neutral. In the first quarter, Westlake showed an EPS of $5.83, compared to $1.87 from the year-ago quarter. The current stock performance of Westlake shows a 52-week-high of $141.19 and a 52-week-low of $78.06. Moreover, at the end of the last trading period, the closing price was at $133.38.
  • According to Barclays, the prior rating for Moody's Corporation MCO was changed from Overweight to Equal-Weight. Moody's earned $2.89 in the first quarter, compared to $4.06 in the year-ago quarter. The stock has a 52-week-high of $407.94 and a 52-week-low of $269.47. At the end of the last trading period, Moody's closed at $293.57.
  • Goldman Sachs downgraded the previous rating for The Travelers Companies Inc TRV from Neutral to Sell. In the first quarter, Travelers Companies showed an EPS of $4.22, compared to $2.73 from the year-ago quarter. The current stock performance of Travelers Companies shows a 52-week-high of $187.98 and a 52-week-low of $144.44. Moreover, at the end of the last trading period, the closing price was at $178.06.
  • CIBC downgraded the previous rating for The Lion Electric Co LEV from Outperformer to Neutral. For the first quarter, Lion Electric had an EPS of $0.01, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $23.45 and a 52-week-low of $4.73. At the end of the last trading period, Lion Electric closed at $5.63.
  • Piper Sandler downgraded the previous rating for Micron Technology Inc MU from Neutral to Underweight. For the second quarter, Micron Technology had an EPS of $2.14, compared to year-ago quarter EPS of $0.98. The current stock performance of Micron Technology shows a 52-week-high of $98.45 and a 52-week-low of $65.67. Moreover, at the end of the last trading period, the closing price was at $75.37.
  • For Aeglea BioTherapeutics Inc AGLE, Needham downgraded the previous rating of Buy to Hold. In the first quarter, Aeglea BioTherapeutics showed an EPS of $0.37, compared to $0.28 from the year-ago quarter. The current stock performance of Aeglea BioTherapeutics shows a 52-week-high of $8.50 and a 52-week-low of $0.71. Moreover, at the end of the last trading period, the closing price was at $0.73.

See all analyst ratings downgrades.

 

Initiations

  • With a Neutral rating, Piper Sandler initiated coverage on Adaptive Biotechnologies Corp ADPT. The price target seems to have been set at $7.50 for Adaptive Biotechnologies. Adaptive Biotechnologies earned $0.44 in the first quarter, compared to $0.29 in the year-ago quarter. The current stock performance of Adaptive Biotechnologies shows a 52-week-high of $43.40 and a 52-week-low of $6.20. Moreover, at the end of the last trading period, the closing price was at $7.99.
  • Oppenheimer initiated coverage on Starry Group Holdings Inc STRY with a Perform rating. The price target for Starry Group Holdings is set to $10.00. At the moment, the stock has a 52-week-high of $10.35 and a 52-week-low of $6.14. Starry Group Holdings closed at $10.26 at the end of the last trading period.
  • Roth Capital initiated coverage on Aravive Inc ARAV with a Buy rating. The price target for Aravive is set to $15.00. For the first quarter, Aravive had an EPS of $0.62, compared to year-ago quarter EPS of $0.44. At the moment, the stock has a 52-week-high of $6.94 and a 52-week-low of $1.02. Aravive closed at $1.22 at the end of the last trading period.
  • Roth Capital initiated coverage on Valmont Industries Inc VMI with a Buy rating. The price target for Valmont Industries is set to $297.00. In the first quarter, Valmont Industries showed an EPS of $3.07, compared to $2.57 from the year-ago quarter. The current stock performance of Valmont Industries shows a 52-week-high of $277.00 and a 52-week-low of $203.31. Moreover, at the end of the last trading period, the closing price was at $259.29.
  • Roth Capital initiated coverage on Lindsay Corp LNN with a Neutral rating. The price target for Lindsay is set to $135.00. For the second quarter, Lindsay had an EPS of $1.32, compared to year-ago quarter EPS of $1.08. The current stock performance of Lindsay shows a 52-week-high of $179.26 and a 52-week-low of $118.28. Moreover, at the end of the last trading period, the closing price was at $135.03.
  • With an Outperform rating, Northland Capital Markets initiated coverage on Xos Inc XOS. The price target seems to have been set at $5.00 for Xos. The stock has a 52-week-high of $9.00 and a 52-week-low of $1.92. At the end of the last trading period, Xos closed at $3.13.
  • Piper Sandler initiated coverage on Invitae Corp NVTA with an Underweight rating. The price target for Invitae is set to $2.50. For the first quarter, Invitae had an EPS of $0.78, compared to year-ago quarter EPS of $0.63. The stock has a 52-week-high of $35.51 and a 52-week-low of $3.30. At the end of the last trading period, Invitae closed at $3.56.
  • With an Overweight rating, Cantor Fitzgerald initiated coverage on ObsEva SA OBSV. The price target seems to have been set at $6.00 for ObsEva. ObsEva earned $0.14 in the first quarter, compared to $0.29 in the year-ago quarter. The current stock performance of ObsEva shows a 52-week-high of $3.58 and a 52-week-low of $1.08. Moreover, at the end of the last trading period, the closing price was at $1.96.
  • With a Buy rating, B of A Securities initiated coverage on CCC Intelligent Solutions Holdings Inc CCCS. The price target seems to have been set at $13.00 for CCC Intelligent Solutions. The current stock performance of CCC Intelligent Solutions shows a 52-week-high of $13.46 and a 52-week-low of $7.41. Moreover, at the end of the last trading period, the closing price was at $9.47.
  • With a Neutral rating, Citigroup initiated coverage on Otonomo Technologies Ltd OTMO. The price target seems to have been set at $1.50 for Otonomo Technologies. The stock has a 52-week-high of $9.48 and a 52-week-low of $1.10. At the end of the last trading period, Otonomo Technologies closed at $1.32.
  • Chardan Capital initiated coverage on Cleanspark Inc CLSK with a Buy rating. The price target for Cleanspark is set to $12.00. Cleanspark earned $0.00 in the second quarter, compared to $0.22 in the year-ago quarter. The current stock performance of Cleanspark shows a 52-week-high of $23.60 and a 52-week-low of $4.53. Moreover, at the end of the last trading period, the closing price was at $5.85.
  • With a Buy rating, Chardan Capital initiated coverage on Marathon Digital Holdings Inc MARA. The price target seems to have been set at $19.00 for Marathon Digital Holdings. For the first quarter, Marathon Digital Holdings had an EPS of $0.02, compared to year-ago quarter EPS of $0.03. At the moment, the stock has a 52-week-high of $83.45 and a 52-week-low of $8.53. Marathon Digital Holdings closed at $9.34 at the end of the last trading period.
  • Chardan Capital initiated coverage on Eqonex Ltd EQOS with a Neutral rating. The price target for Eqonex is set to $1.25. The current stock performance of Eqonex shows a 52-week-high of $9.67 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $1.11.
  • Chardan Capital initiated coverage on Core Scientific Inc CORZ with a Buy rating. The price target for Core Scientific is set to $8.00. The stock has a 52-week-high of $11.49 and a 52-week-low of $2.94. At the end of the last trading period, Core Scientific closed at $3.04.
  • Needham initiated coverage on Loyalty Ventures Inc LYLT with a Buy rating. The price target for Loyalty Ventures is set to $16.00. At the moment, the stock has a 52-week-high of $52.50 and a 52-week-low of $9.44. Loyalty Ventures closed at $11.14 at the end of the last trading period.
  • Baird initiated coverage on Fate Therapeutics Inc FATE with a Neutral rating. The price target for Fate Therapeutics is set to $28.00. For the first quarter, Fate Therapeutics had an EPS of $0.68, compared to year-ago quarter EPS of $0.48. The current stock performance of Fate Therapeutics shows a 52-week-high of $97.43 and a 52-week-low of $20.49. Moreover, at the end of the last trading period, the closing price was at $23.36.
  • With a Neutral rating, Baird initiated coverage on Allogene Therapeutics Inc ALLO. The price target seems to have been set at $11.00 for Allogene Therapeutics. For the first quarter, Allogene Therapeutics had an EPS of $0.56, compared to year-ago quarter EPS of $0.25. The current stock performance of Allogene Therapeutics shows a 52-week-high of $27.86 and a 52-week-low of $6.42. Moreover, at the end of the last trading period, the closing price was at $7.87.
  • With a Perform rating, Piper Sandler initiated coverage on Starry Group Holdings Inc STRY. The price target seems to have been set at $10.00 for Starry Group Holdings. The stock has a 52-week-high of $10.35 and a 52-week-low of $6.14. At the end of the last trading period, Starry Group Holdings closed at $10.26.
  • With an Overweight rating, Piper Sandler initiated coverage on Guardant Health Inc GH. The price target seems to have been set at $65.00 for Guardant Health. In the first quarter, Guardant Health showed an EPS of $0.91, compared to $0.49 from the year-ago quarter. The current stock performance of Guardant Health shows a 52-week-high of $133.82 and a 52-week-low of $27.65. Moreover, at the end of the last trading period, the closing price was at $41.44.
  • Piper Sandler initiated coverage on NeoGenomics Inc NEO with an Overweight rating. The price target for NeoGenomics is set to $13.00. For the first quarter, NeoGenomics had an EPS of $0.20, compared to year-ago quarter EPS of $0.04. The current stock performance of NeoGenomics shows a 52-week-high of $54.74 and a 52-week-low of $7.26. Moreover, at the end of the last trading period, the closing price was at $8.67.
  • Piper Sandler initiated coverage on Exact Sciences Corp EXAS with a Neutral rating. The price target for Exact Sciences is set to $50.00. Exact Sciences earned $1.04 in the first quarter, compared to $0.18 in the year-ago quarter. The stock has a 52-week-high of $133.99 and a 52-week-low of $46.15. At the end of the last trading period, Exact Sciences closed at $51.22.
  • With an Outperform rating, Raymond James initiated coverage on Snowflake Inc SNOW. The price target seems to have been set at $184.00 for Snowflake. In the first quarter, Snowflake showed an EPS of $0.08, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $405.00 and a 52-week-low of $112.10. Snowflake closed at $138.24 at the end of the last trading period.

See all analyst ratings initiations.

Posted In: BZI-RatingsUpgradesDowngradesInitiationIntraday UpdateAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.